Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of Post-Operative Sensitivity of 5th Genaration Bonding Agent With 8th Generation Bonding Agent in Class1 Composite Restoration

NCT: NCT07862270 · COMPLETED

NCT IDNCT07862270
StatusCOMPLETED
Start Date2026-03-01
Completion2026-08-30
SponsorRehman Medical Institute - RMI (OTHER)
First posted
Last updated

Brief Summary

The goal of this randomized clinical trial is to compare post-operative sensitivity after Class I composite restorations using 5th-generation and 8th-generation bonding agents in adults aged 18 to 50 years. The main question is whether the level of sensitivity differs between the two bonding agents. Participants will be randomly assigned to receive either a 5th-generation or an 8th-generation bonding agent during their composite restoration. Sensitivity will be measured using a 0-10 Visual Analogue Scale immediately after treatment, at 24 hours, and at 7 days after treatment.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑